ArticleThe Journal of clinical investigation2020

BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo.

Yanqin Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.